Amundi

SEC CIK: 0001330387
Latest filing: Aug 26, 2026

SEC filings (opens in a new tab)

PHAT holding history

Phathom Pharmaceuticals, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PHAT overview All 13F holders of PHAT Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2021

Holdings of PHAT by Amundi, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−42−100.0%	Sold out	Holders
Q1 2025	42	$210	<0.1%	00.0%	Unchanged	Holders
Q4 2024	42	$292	<0.1%	+42	New	Holders
Q3 2021	0	$0	0.0%	−4,513−100.0%	Sold out	Holders
Q2 2021	4,513	$153.0K	<0.1%	–	No prior filing	Holders